GlassScriptPhysician profile
Sunita A Dwivedi
NPI 1366590077
$3,279.90
in general payments reported to CMS, 2019-2025
20 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $507 · 2020: $277 · 2021: $530 · 2022: $328 · 2023: $826 · 2024: $340 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,638.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $431.50 | 2019-2025 | Ozempic |
| Pfizer INC. | $367.42 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $358.75 | 2024-2025 | Voquezna |
| Glaxosmithkline, LLC. | $244.63 | 2020-2023 | Shingrix, Arexvy |
| Lilly USA, LLC | $239.18 | 2019-2024 | Mounjaro |
| Silk Road Medical, INC. | $224.90 | 2021 | |
| Sanara Medtech INC. | $213.85 | 2022-2023 | Celleraterx |
| Penumbra, INC. | $177.00 | 2021 | |
| Stryker Corporation | $133.65 | 2025 | Artix Mt |
| Amgen INC. | $125.06 | 2019-2023 | Repatha |
| Cvrx, INC. | $124.99 | 2022 | |
| Idorsia Pharmaceuticals US INC | $119.70 | 2023 | Quviviq |
| Janssen Pharmaceuticals, INC | $117.66 | 2020-2021 | |
| Abbvie INC. | $101.33 | 2023 | Vraylar |
| Acera Surgical, INC. | $90.22 | 2024 | Restrata Wound Matrix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avinger INC. | $81.00 | 2023 | Pantheris |
| Dexcom, INC. | $69.71 | 2023 | Dexcom G7 Gss (161) |
| E.R. Squibb & Sons, L.L.C. | $26.65 | 2020-2021 | |
| Abbott Laboratories | $16.74 | 2021 | |
| Lemaitre Vascular, INC. | $15.96 | 2024 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunita Dwivedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.